The Royal Marsden Hospital — London

Public research footprint of The Royal Marsden Hospital, compiled from the ClinicalTrials.gov public registry.

157

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Gastroesophageal Junction Adenocarcinoma · Unresectable Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT03888105 — A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients… (Active Not Recruiting)
NCT04886804 — Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different… (Active Not Recruiting)
NCT06031441 — A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Royal Marsden Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.